The renewal of the IFS Progress Food 2026 certificate strengthens internal control over traceability and documentation for industrial customers in the botanical and nutraceutical segment. This intermediate approval validates criteria required in the B2B link of the supply chain: food safety and the consistency of technical specifications become stronger when the supplier demonstrates effective batch control systems and monitoring protocols supported by an independent audit.
IFS Progress Food provides an assessment framework that prioritises transparency, regulatory compliance and the systematic detection of deviations across the ingredient supply chain. In our operations, applying this standard means ensuring that each botanical extract has a documented history, verified sourcing routes and batch systems capable of responding quickly to external audits, product withdrawals or regulatory requirements in different markets.
Technical precision: document control and comprehensive batch management
A robust traceability system not only meets regulatory standards, but also accelerates response management in the event of product alerts and reinforces trust in ingredients sourced from different geographical origins. For supplement laboratories and functional food companies, origin traceability supports internal and external audits, minimises incidents and helps prevent cross-contamination, in line with the protocols established by current European regulations: Regulation 178/2022, 2015/2283 and 1169/2011.
The specifications guaranteed under IFS support the integration of extracts as functional ingredients in production lines that require quality certification. This enables R&D teams to accelerate adaptation to new formulas, respond to customisation needs and protect the documentary chain during inspections by international customers.
Industrial approach: standardisation and technological formulation solutions
The development of standardised ingredients requires active marker quantification techniques and cross-batch validation. From a technical perspective, the clear demand is: stability of the active compound, control of critical parameters such as moisture, heavy metals and pesticides, and batch-to-batch analytical consistency.
The implementation of technologies such as microencapsulation, nanoemulsion or liposomal formulations expands the range of application options in functional matrices, facilitating the inclusion of botanical extracts in liquids, powders and premixes adapted to the B2B industry.
Technical teams value the support of a recognised international certification, especially when traceability, supply flexibility and documentary support have a direct impact on the R&D cycle and on the agility required to access regulated markets. The option to adapt batch sizes or specific dosage forms increases the appeal for formulators seeking both differentiation and compliance.
The information provided in this article is for informational purposes only and does not constitute medical, nutritional or regulatory advice.